NewsBenzingaDaré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies Benzinga 2026.09.28 12:21 (GMT+0) Open on Benzinga Other news What's Going On with Robinhood Stock Monday? RBC Capital Downgrades Cannae Holdings to Sector Perform, Raises Price Target to $18 Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients Wells Fargo Maintains Equal-Weight on Gaming and Leisure Props, Lowers Price Target to $39 Reading Intl Q3 EPS $0.02 Up From $(0.18) YoY, Sales $65.280M Up From $52.170M YoY Argus Research Maintains Buy on Intercontinental Exchange, Raises Price Target to $198